NGM Biopharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This ESG rating covers 17 United Nations SDGs including: 'Clean Water & Sanitation', 'Climate Action' and 'Peace, Justice & Strong Institutions'. Full ESG assessment of NGM Biopharmaceuticals Inc are accessed by logging in. The report of NGM Biopharmaceuticals Inc incorporates information from across the web and also from available documents by NGM Biopharmaceuticals Inc.
NGM Biopharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.5; made up of an environmental score of 0.0, social score of 1.6 and governance score of 0.0.
0.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1898 | Zota Health Care Ltd | 0.7 | Low |
| 1898 | cbdMD Inc | 0.7 | Low |
| 1924 | NGM Biopharmaceuticals Inc | 0.5 | Low |
| 1924 | Beximco Pharmaceuticals Ltd | 0.5 | Low |
| 1924 | Acucela Inc | 0.5 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does NGM Biopharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid NGM Biopharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas NGM Biopharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs NGM Biopharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes NGM Biopharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes NGM Biopharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for NGM Biopharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trials for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an antagonist antibody that binds GFRAL that is in Phase I/II clinical trials; NGM621, an immunoglobulin 1 monoclonal antibody in Phase II clinical trials for the treatment of geographic atrophy; NGM707, an immunoglobulin-like transcript 2/ immunoglobulin-like transcript 4 dual antagonist monoclonal antibody that is in Phase I/II clinical trials for the treatment of patients with advanced solid tumors; and NGM831 and NGM438 for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp.; and a collaboration agreement with Merck & Co., Inc. to focus primarily on the development of novel medicines for unmet patient needs in retinal and CVM diseases, including heart failure. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.